
Serbian scientists sell autoimmune disease and cancer treatment for USD 1.9 billion – Sanofi buys biopharma company Dren ...
Pharma-major Sanofi has acquired Serbian-founded biopharmaceutical company Dren Bio for up to USD 1.9 billion. Dren Bio is headquartered in San Francisco and it was founded by Serbian scientists. As said in a joint statement by the companies, this …